This is an old revision of this page, as edited by Svampesky (talk | contribs) at 19:36, 28 December 2024 (Ce on new article.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 19:36, 28 December 2024 by Svampesky (talk | contribs) (Ce on new article.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article relies largely or entirely on a single source. Please help improve this article by introducing citations to additional sources. Find sources: "Bladder tumor antigen" – news · newspapers · books · scholar · JSTOR |
The bladder tumour antigen (BTA) test is used in the detection of bladder cancer. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the amount of the antigen is measured.
References
- Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K (September 2022). "Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis". BJUI Compass. 3 (5): 334–343. doi:10.1002/bco2.147. PMC 9349596. PMID 35950042.